SciELO - Scientific Electronic Library Online

 
vol.28 número1Recém-nascidos com sepse por Estafilococos aureus e coagulasa-negativo tratados com Vancomicina, após aumento do nível sérico no vale índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

artigo

Indicadores

Compartilhar


Journal of Human Growth and Development

versão impressa ISSN 0104-1282versão On-line ISSN 2175-3598

Resumo

SORPRESO, Isabel Cristina Esposito  e  KELLY, Patricia Jane. HPV vaccine: knowledge and acceptance to ensure effectiveness. J. Hum. Growth Dev. [online]. 2018, vol.28, n.1, pp.5-8. ISSN 0104-1282.  https://doi.org/10.7322/jhgd.143887.

The new Vaccine technologies against transmissible and non-transmissible diseases, such as cancer, have had an impact on international public health. The human papillomavirus (HPV) vaccine is used on a large scale in immunization programs in more than 58 countries, with resultant efficacy and safety for precursor lesions of cervical cancer, in addition to anogenital lesions. After the introduction of quadrivalent HPV vaccine (6,11,16 and 18) in Brazil in 2014, monitoring the vaccination coverage and the development of HPV prevalence incidence of cervical abnormalities and precancerous lesions must be observed, as well as morbidity and mortality trends from in situ and invasive cancer. Encouraging information, counseling and continuing education is recommended as a strategy to broaden vaccine acceptance in order to sediment its implementation and ensure effectiveness in reducing new cases of cervical cancer in the future.

Palavras-chave : HPV; papillomavirus vaccines; human papillomavirus recombinant vaccine quadrivalent, types 6;11;16;18; uterine cervical neoplasms.

        · resumo em Português     · texto em Inglês     · Português ( pdf ) | Inglês ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons